Clinical Trial Update: Hypofractionated Radiotherapy for Postoperative Intermediate-Risk Head and Neck Squamous Cell Carcinoma [NA]

View source ↗

Summary

Clinical trial update on hypofractionated radiotherapy as postoperative treatment for intermediate-risk head and neck squamous cell carcinoma; the study is not …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Squamous Cell Carcinoma

Snippet

Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences | Conditions: Head and Neck Squamous Cell Carcinoma | NA | Status: NOT_YET_RECRUITING